Prot #C34002: An Open-Label, Phase 1b/2 Study Investigating Recommended Phase 2 Dose, Safety, Tolerability, and Preliminary Efficacy of TAK-659 in Adult Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

  • Frankfurt, Olga (PD/PI)
  • Kaplan, Jason B (Other)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/25/15 → 2/28/21

Funding

  • Quintiles, Inc. (Prot #C34002 // Prot #C34002)
  • Millennium Pharmaceuticals, Inc. (Prot #C34002 // Prot #C34002)